Chemical and Biological Defense Program - Office of the Under ...

UNCLASSIFIED
Exhibit P-5, Cost Analysis: PB 2014 Chemical and Biological Defense Program Date: April 2013
Appropriation / Budget Activity / Budget Sub Activity:
0300D: Procurement, Defense-Wide / BA 03: Chemical/
Biological Defense / BSA 1: CBDP
P-1 Line Item Nomenclature:
MA0800 - JOINT BIO DEFENSE PROGRAM (MEDICAL)
Resource Summary Prior Years FY 2012 FY 2013 #
LI MA0800 - JOINT BIO DEFENSE PROGRAM (MEDICAL) UNCLASSIFIED
Chemical and Biological Defense Program Page 3 of 17 P-1 Line #92
Item Nomenclature (Item Number - Item
Name, DODIC):
JM6677 - ADVANCED
ANTICONVULSANT SYSTEM (AAS)
FY 2014 Base FY 2014 OCO ##
FY 2014 Total
Procurement Quantity (Units in Each) - - - - - -
Gross/Weapon System Cost ($ in Millions) 0.000 - 4.466 8.951 - 8.951
Less PY Advance Procurement ($ in Millions) - - - - - -
Net Procurement (P1) ($ in Millions) 0.000 - 4.466 8.951 - 8.951
Plus CY Advance Procurement ($ in Millions) - - - - - -
Total Obligation Authority ($ in Millions) 0.000 - 4.466 8.951 - 8.951
(The following Resource Summary rows are for informational purposes only. The corresponding budget requests are documented elsewhere.)
Initial Spares ($ in Millions) - - - - - -
Gross/Weapon System Unit Cost (Units in Thousands) - - - - - -
# FY 2013 Program is from the FY 2013 President's Budget, submitted February 2012
## The FY 2014 OCO Request will be submitted at a later date
Cost Elements
(† indicates the
presence of a P-5A)
Hardware Cost
Recurring Cost
ID Unit Cost
CD ($ K )
All Prior Years FY 2012 FY 2013 FY 2014 Base FY 2014 OCO FY 2014 Total
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
† AAS - Procurement - - 0.000 - - - 0.017 150,000 2.550 0.017 450,000 7.650 - - - 0.017 450,000 7.650
Total Recurring Cost 0.000 - 2.550 7.650 - 7.650
Total Hardware Cost 0.000 - 2.550 7.650 - 7.650
Support Cost
AAS - Program
Management
Total
Cost
($ M )
Unit Cost
($ K )
- - 0.000 - - - - - 1.916 - - 1.301 - - - - - 1.301
Total Support Cost 0.000 - 1.916 1.301 - 1.301
Gross Weapon System
Cost
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
Total
Cost
($ M )
Unit Cost
($ K )
Quantity
(Each)
0.000 - 4.466 8.951 - 8.951
P-5 Remarks:
The Advanced Anticonvulsant System (AAS) will consist of the drug midazolam in an autoinjector for use in treating nerve agent induced seizures and will replace the currently fielded Convulsant Antidote for
Nerve Agent (CANA) autoinjector, which uses diazepam. FY 2013, FY 2014 and FY 2015 support initial procurement for Initial Operational Capability (IOC) and Full Operational Capability (FOC) supporting the
AAS phase-in/CANA phase-out plan along with transitioning the program to the Defense Logistics Agency (DLA) in FY 2015 for sustainment.
Justification: FY 2014 funding supports procurement of IOC and FOC.
RDT&E Code B Item: 0604384BP/Proj MC5
Total
Cost
($ M )
49